Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Brunetti

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Cancer Discovery|December 1, 2022
Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid LeukemiaHannah J Uckelmann, Elena L Haarer, Reina Takeda, et al.
Blood Advances|August 29, 2022
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AMLGiulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, et al.
Blood Advances|September 7, 2021
Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilitiesJason H Rogers, Rohit Gupta, Jaime M Reyes, et al.
Cancer Cell|September 12, 2018
Mutant NPM1 Maintains the Leukemic State through HOX ExpressionLorenzo Brunetti, Michael C Gundry, Daniele Sorcini, et al.
Cell Reports|November 24, 2023
An atypical GABARAP binding module drives the pro-autophagic potential of the AML-associated NPM1c variantHannah Mende, Anshu Khatri, Carolin Lange, et al.
Leukemia|November 7, 2020
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in micePaolo Sportoletti, Daniele Sorcini, Anna G Guzman, et al.
Nature Communications|May 20, 2020
TFEB regulates murine liver cell fate during development and regenerationNunzia Pastore, Tuong Huynh, Niculin J Herz, et al.
Hematological Oncology|January 13, 2026
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON CohortCalogero Vetro, Irene Azzali, Elisabetta Petracci, et al.
Leukemia|March 3, 2021
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AMLIlaria Gionfriddo, Lorenzo Brunetti, Federica Mezzasoma, et al.
Blood|July 17, 2010
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised miceMaria Paola Martelli, Valentina Pettirossi, Christian Thiede, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Cancer Discovery|December 1, 2022
Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid LeukemiaHannah J Uckelmann, Elena L Haarer, Reina Takeda, et al.
Blood Advances|August 29, 2022
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AMLGiulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, et al.
Blood Advances|September 7, 2021
Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilitiesJason H Rogers, Rohit Gupta, Jaime M Reyes, et al.
Cancer Cell|September 12, 2018
Mutant NPM1 Maintains the Leukemic State through HOX ExpressionLorenzo Brunetti, Michael C Gundry, Daniele Sorcini, et al.
Cell Reports|November 24, 2023
An atypical GABARAP binding module drives the pro-autophagic potential of the AML-associated NPM1c variantHannah Mende, Anshu Khatri, Carolin Lange, et al.
Leukemia|November 7, 2020
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in micePaolo Sportoletti, Daniele Sorcini, Anna G Guzman, et al.
Nature Communications|May 20, 2020
TFEB regulates murine liver cell fate during development and regenerationNunzia Pastore, Tuong Huynh, Niculin J Herz, et al.
Hematological Oncology|January 13, 2026
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON CohortCalogero Vetro, Irene Azzali, Elisabetta Petracci, et al.
Leukemia|March 3, 2021
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AMLIlaria Gionfriddo, Lorenzo Brunetti, Federica Mezzasoma, et al.
Blood|July 17, 2010
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised miceMaria Paola Martelli, Valentina Pettirossi, Christian Thiede, et al.
Pageof 6